SCHEMBL29617613

SCHEMBL29617613

O=C(O)C[C@@H]1C[C@@H](c2ccc(C(F)(F)F)cc2)CN(Cc2ccc(Cl)cc2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 2/20 0.48
PSEN2 P49810 2/20 0.48
APH1B Q8WW43 2/20 0.48
NCSTN Q92542 2/20 0.48
APH1A Q96BI3 2/20 0.48
PSENEN Q9NZ42 2/20 0.48
OPRL1 P41146 1/20 0.44
CHRM2 P08172 1/20 0.43
CHRM5 P08912 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
HIF1A Q16665 1/20 0.42
EPAS1 Q99814 1/20 0.42
FAAH O00519 1/20 0.42
S1PR5 Q9H228 3/20 0.41
S1PR1 P21453 2/20 0.41
GRK5 P34947 1/20 0.41
CDK8 P49336 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29087732 1.00 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30646794 1.00 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29087735 1.00 PSEN1 (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29087738 0.95 CHRM2 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29617639 0.95 CHRM2 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29087736 0.95 CHRM2 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30646804 0.91 TACR1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29087765 0.91 TACR1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL29087782 0.91 S1PR5 (0.48) FAAHS1PR5S1PR1
SCHEMBL29087786 0.91 S1PR5 (0.48) FAAHS1PR5S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230416202-A1 Small Molecule Compounds and Compositions TELO THERAPEUTICS, INC. 2023-12-28 US disclosed
EP-4247374-A1 SMALL MOLECULE COMPOUNDS AND COMPOSITIONS Telo Therapeutics, Inc. (US) 2023-09-27 EP disclosed
CN-116710431-A Small molecule compounds and compositions 泰洛治疗公司 2023-09-05 CN disclosed
WO-2022109209-A1 SMALL MOLECULE COMPOUNDS AND COMPOSITIONS TELO THERAPEUTICS, INC. (US) 2022-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230416202-A1 Small Molecule Compounds and Compositions TERT, TP53, EP300 PSEN1 784/4885PSEN2 581/4885APH1B 1982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.